The general objective of the iPAAC Joint Action (JA) is to develop innovative approaches to advances in cancer control. The innovation that will be covered within the JA consists of further development of cancer prevention, comprehensive approaches to the use of genomics in cancer control, cancer information and registries, improvements and challenges in cancer care, mapping of innovative cancer treatments and governance of integrated cancer control, including a new analysis of National Cancer Control Plans. The key focus of the Joint Action will be on implementation, as reflected in the key deliverable, i.e. the Roadmap on Implementation and Sustainability of Cancer Control Actions, which will support member states in the implementation of iPAAC and CANCON recommendations.
million EUR co-funding by EC
44 partners (Competent Authorities and Affiliated Entities)
30 Oct 2018
WP4 visits in EU countries
The iPAAC WP4 team is currently visiting EU Member States to collect their experience in the implementation of cancer control programs.
02 Oct 2018
The first iPAAC Stakeholder Forum, 20 September 2018, Brussels
The first iPAAC Stakeholder Forum was held in the conference room of the Belgian Ministry of Employment in Brussels on Thursday, 20 September 2018.
08 Jul 2018
Innovative Therapies in Cancer (WP 9) kick-off meeting in Boulogne
A kick-off meeting of the work package 9 was held on 2–3 July 2018 at the French National Cancer Institute (INCa), Boulogne Billancourt.
01 Jul 2018
Governmental Board & Roadmap Coordination Committee kick-off meeting in Brussels
iPAAC work package 4 (Integration in national policies and sustainability) was launched by two working groups meetings in Brussels on 27–28 June 2018.